Merck & Co. headquarters in Kenilworth, N.J. United Nations-backed Medicines Patent Pool reached an agreement with Merck and its partner Ridgeback Biotherapeutics allowing MPP to license the manufacture of molnupiravir to pharmaceutical companies across the globe. Christopher Occhicone/Bloomberg via Getty Images hide caption toggle caption Christopher Occhicone/Bloomberg via Getty Images Merck & Co. headquarters in…
